| AI serves up target and inhibitor for lung fibrosis | 2024/03/20 | English | |
| FDA approves Merck & Co’s pulmonary arterial hypertension drug sotatercept | 2024/03/27 | English | |
| NASH field celebrates ‘hurrah moment’ with a first FDA drug approval for the liver disease | 2024/03/14 | English | |
| Upcoming market catalysts in Q2 2023 | 2023/03/03 | English | |
| Biopharma dealmaking in 2023 | 2024/01/16 | English | |
| Open science in precision medicine for neurodegenerative diseases | 2024/01/29 | English | |
| 2023 FDA approvals: unprecedented volume at moderate value | 2024/01/17 | English | |
| The case for cell-penetrating peptides | 2023/06/29 | English | |
| Upcoming market catalysts in Q3 2023 | 2023/06/14 | English | |
| FDA new drug approvals in Q2 2023 | 2023/07/11 | English | |
| Reading through stop codons with engineered tRNAs | 2023/06/27 | English | |
| A cancer drug wish list | 2023/06/15 | English | |
| Massive misuse of chemical probes undermines the utility of these tools | 2023/06/30 | English | |
| CRISPR base editing protects the heart | 2023/02/01 | English | |
| RNA-editing drugs advance into clinical trials | 2024/04/18 | English | |
| Three-step cures for autoimmune diseases? | 2024/04/17 | English | |
| Targeting immunogenic cell stress and death for cancer therapy | 2024/04/15 | English | |
| mRNA therapy shows promise for metabolic disorder | 2024/04/23 | English | |
| The antibody–drug conjugate landscape | 2024/04/16 | English | |
| Approvals by the China NMPA in 2023 | 2024/02/19 | English | |
| When can AI deliver the drug discovery hits? | 2024/02/19 | English | |
| New NIH director’s research agenda spans “the laboratory, the clinic and the community” | 2024/02/19 | English | |
| The early results of misfolding | 2002/05/01 | English | |
| In this issue | 2002/02/01 | English | |
| In this issue | 2002/05/01 | English | |
| Antipsychotic displays dual GPCR binding mode | 2023/09/26 | English | |
| Chemoproteomic trailblazer advances covalent candidate into the clinic, pushes allosteric agenda | 2023/08/14 | English | |
| Clipping cell-surface mucins in cancer by targeted degradation | 2023/08/25 | English | |
| Macrocycle drugs serve up new opportunities | 2023/09/11 | English | |
| Peptide vaccine turns up the heat in ALK-positive cancers | 2023/07/31 | English | |